Literature DB >> 12226757

Cell transformation by v-Jun deactivates ERK MAP kinase signalling.

Elizabeth J Black1, Mark Walker, William Clark, Ann MacLaren, David A F Gillespie.   

Abstract

Previous studies have shown that v-Jun accelerates G1 progression and enables cells to sustain S phase entry in the absence of serum growth factors. Since growth factor-dependent ERK MAP kinase signalling plays an important role in regulating the G1/S transition, we investigated whether aberrant ERK regulation might contribute to cell cycle deregulation by v-Jun. Contrary to expectation, we find that cells transformed by v-Jun exhibit a profound reduction in the basal level of active, dual-phosphorylated ERK. In addition, ERK becomes refractory to stimulation by a subset of agonists including serum, LPA, and EGF, but remains partially responsive to the phorbol ester, TPA. Biochemical analysis indicates that these defects are attributable to a combination of inefficient signal propagation between Ras and Raf within the ERK pathway and increased tonic deactivation by MAP kinase phosphatases. Taken together, these results demonstrate that cell transformation by v-Jun induces alterations in cell physiology which antagonize ERK signalling at multiple levels. The potential significance of this phenotype for oncogenesis by v-Jun is discussed.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12226757     DOI: 10.1038/sj.onc.1205851

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  7 in total

1.  An approach to investigate intracellular protein network responses.

Authors:  Holly N Currie; Julie A Vrana; Alice A Han; Giovanni Scardoni; Nate Boggs; Jonathan W Boyd
Journal:  Chem Res Toxicol       Date:  2014-01-03       Impact factor: 3.739

2.  p75-Ras-GRF1 is a c-Jun/AP-1 target protein: its up regulation results in increased Ras activity and is necessary for c-Jun-induced nonadherent growth of Rat1a cells.

Authors:  Virna D Leaner; Howard Donninger; Chad A Ellis; Geoffrey J Clark; Michael J Birrer
Journal:  Mol Cell Biol       Date:  2005-04       Impact factor: 4.272

3.  MEKK2 kinase association with 14-3-3 protein regulates activation of c-Jun N-terminal kinase.

Authors:  Adi E Matitau; Timothy V Gabor; R Montgomery Gill; Michael P Scheid
Journal:  J Biol Chem       Date:  2013-08-20       Impact factor: 5.157

4.  Inactivation of MAP kinase signalling in Myc transformed cells and rescue by LiCl inhibition of GSK3.

Authors:  Osama Al-Assar; Dorothy H Crouch
Journal:  Mol Cancer       Date:  2005-04-05       Impact factor: 27.401

5.  Systemic inflammation suppresses spinal respiratory motor plasticity via mechanisms that require serine/threonine protein phosphatase activity.

Authors:  Arash Tadjalli; Yasin B Seven; Raphael R Perim; Gordon S Mitchell
Journal:  J Neuroinflammation       Date:  2021-01-19       Impact factor: 8.322

6.  Crosstalk and signaling switches in mitogen-activated protein kinase cascades.

Authors:  Dirk Fey; David R Croucher; Walter Kolch; Boris N Kholodenko
Journal:  Front Physiol       Date:  2012-09-18       Impact factor: 4.566

7.  Mathematical model of a telomerase transcriptional regulatory network developed by cell-based screening: analysis of inhibitor effects and telomerase expression mechanisms.

Authors:  Alan E Bilsland; Katrina Stevenson; Yu Liu; Stacey Hoare; Claire J Cairney; Jon Roffey; W Nicol Keith
Journal:  PLoS Comput Biol       Date:  2014-02-13       Impact factor: 4.475

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.